Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Inventory (2019 - 2025)

Historic Inventory for Pharming (PHAR) over the last 6 years, with Q4 2024 value amounting to $55.7 million.

  • Pharming's Inventory fell 189.44% to $55.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $55.7 million, marking a year-over-year decrease of 189.44%. This contributed to the annual value of $55.7 million for FY2024, which is 189.44% down from last year.
  • Per Pharming's latest filing, its Inventory stood at $55.7 million for Q4 2024, which was down 189.44% from $56.8 million recorded in Q4 2023.
  • Over the past 5 years, Pharming's Inventory peaked at $56.8 million during Q4 2023, and registered a low of -$2.4 million during Q4 2021.
  • Moreover, its 5-year median value for Inventory was $20.5 million (2020), whereas its average is $25.7 million.
  • As far as peak fluctuations go, Pharming's Inventory crashed by 11191.71% in 2021, and later soared by 298178.59% in 2023.
  • Quarter analysis of 5 years shows Pharming's Inventory stood at $20.5 million in 2020, then crashed by 111.92% to -$2.4 million in 2021, then rose by 19.49% to -$2.0 million in 2022, then soared by 2981.79% to $56.8 million in 2023, then fell by 1.89% to $55.7 million in 2024.
  • Its last three reported values are $55.7 million in Q4 2024, $56.8 million for Q4 2023, and -$2.0 million during Q4 2022.